Introduction
Ubiquitin-mediated proteolysis is responsible for the turnover of select cellular regulators. In this pathway, multi-ubiquitin chains are covalently attached to target substrates which are then degraded by the 26S proteasome. Recent evidence has extended the list of targets controlled by ubiquitination to include, among others, the tumor suppressors p53 and RB, the cell cycle regulators cyclin A, cyclin B, cyclin E and p27, the Ser/Thr kinase c-mos, the transcription factors E2F, NF-kB/IkB, the proto-oncogenes c-myc, c-jun and c-fos, and membrane proteins such as the cystic ®brosis transmembrane conductance regulator (CFTR) and the IgE surface receptor (for reviews, see Hochstrasser, 1995; Pahl and Baeurele, 1996; . Aberrations in the regulated destruction of such key cellular substrates can have profound physiological consequences for the cell and may underlie certain pathological conditions. The transfer of ubiquitin to the target substrate is a multi-step process. Ubiquitin is ®rst activated in an ATP-requiring step by an E1 enzyme, transferred to one of a small family of conjugation enzymes (E2s, or UBCs) and ®nally onto the substrate. The requirement for an additional activity, E3, has been convincingly demonstrated in a few instances, the ®rst being the recognition component of the N-end-rule pathway in the yeast S. cerevisiae encoded by the UBR1 gene (Varshavsky, 1996) . Two well-characterized examples in mammalian cells suggest that E3s comprise a structurally diverse group. In one case, the degradation of p53 in cells infected with human papilloma virus (HPV) is mediated by a complex between the viral E6 and a cellular protein, E6AP (Beer-Romero et al., 1997; Rolfe et al., 1995; Schener et al., 1995) . The latter is the founding member of a family of related enzymes sharing a motif that contains the catalytic cysteine involved in thioester formation with ubiquitin. In the second case, the E3 activity required for the degradation of mitotic cyclins (known as the cyclosome or APC) comprises eight subunits, none of which appear to form a covalent linkage with ubiquitin (King et al., 1995) . Thus, E3s promise to be the major determinants of speci®city for the ubiquitination of a given target. Furthermore, there is compelling evidence that ubiquitin conjugation of many proteins is also regulated by phosphorylation events (Chen et al., 1996; Hicke and Riezman, 1996; Musti et al., 1997) .
Another class of enzymes postulated to have potential substrate selectivity are the deubiquitination enzymes (DUBs). These can be further grouped by sequence similarity into two main families, the ubiquitin-carboxy-terminal hydrolases (UCHs), and the ubiquitin-speci®c proteases (UBPs). The latter comprise a large and diverse group with at least 16 members in the budding yeast alone and more estimated in humans from the expressed sequence tag (EST) databases. They share two signature motifs (The Cys box and the His box) that presumably constitute the catalytic active site (Papa and Hochstrasser, 1993) . Although the physiological substrates for these enzymes have yet to be identi®ed, they can all cleave ubiquitin from an engineered ubiquitin-protein fusion substrate in a bacterial assay. Their best characterized member, isopeptidase T, can remove ubiquitins processively from a multi-ubiquitin chain in vitro, thereby functioning to recycle free ubiquitin, and is expected to have a general, rather than a speci®c eect on cellular targets (Wilkinson et al., 1995) . One reason for the excitement over these enzymes, however, comes from their possible role as target-speci®c regulators. Many UBPs have been identi®ed in genetic screens whose mutant phenotypes or patterns of expression implicate cellular processes as diverse as eye development in fruit¯y (Fischer-Vize et al., 1992; Huang et al., 1995) , transcriptional silencing (Moazed and Johnson, 1996) , stability of the yeast MATa2 transcription factor (Papa and Hochstrasser, 1993) , cytokine response (Zhu et al., 1996 (Zhu et al., , 1997 , and oncogenesis (Nakamura et al., 1992) . Most recently, a member of the UCH family was implicated in long-term facilitation of neuronal synapses in Aplysia (Hegde et al., 1997) . Whether such expectation will be ful®lled will require identi®cation of the physiological substrates for these enzymes and characterization of their selectivity (reviewed in Hochstrasser, 1995; Kalderon, 1996) .
In this paper we present molecular characterization of a deubiquitinating enzyme, human UNP. Unp was originally identi®ed during a survey of mouse genes near the Mpv20 retroviral insertion site, and named for what the authors considered a ubiquitous nuclear protein. Analysis of the mouse cDNA revealed sequence homology to the UBP family, in particular that of the tre oncogene (Gupta et al., 1993) . In another study, Unp was found to specify two related mRNAs that are ubiquitously expressed. Evidence for nuclear localization and transforming potential of UNP in athymic mice was also published (Gupta et al., 1994) . Subsequently, the human cDNA homolog of Unp was isolated (Unph) and found to hybridize to chromosome band 3p21.3, a locus frequently rearranged in lung cancers. The authors then surveyed a panel of lung tumors as well as lung tumor cell lines and concluded that levels of Unp mRNA expression are consistently elevated in small cell tumors and adenocarcinomas of the lung (Gray et al., 1995) . Intrigued by its possible role in the pathology of small cell lung cancer, we began the characterization of human Unp. Here we present results that suggest alternative interpretations to a number of the previously published observations on Unp.
a Human UNP encodes two cytoplasmic ubiquitin proteases A Frederick et al
Results

Identi®cation of Unp cDNA isoforms
We isolated overlapping human Unp cDNA clones from three adult tissue sources: B lymphocyte, T lymphocyte and retinal libraries (see Materials and methods), and used them to assemble a nucleotide sequence containing the longest uninterrupted reading frame for Unp (Figure 1a) . We also determined the sequence of a fetal spleen cDNA clone from the EST database derived from Unp (clone 72923). When the sequences were compared to one another and to the published human Unph sequence (Gray et al., 1995;  accession number U20657), we found numerous dierences, summarized in Table 1 and Figure 1 . To avoid confusion, we refer to the prototype sequence shown in Figure 1a , as UnpEL (extended, long isoform), to the published sequence as Unph, and to the locus encoding all cDNA derivatives, Unp.
First, the open reading frame of UnpEL predicts a protein that is longer at both the amino-and carboxytermini than the published Unph sequence by a total of 109 amino acid residues, and 13 kDa dierence in predicted molecular mass. The dierences were entirely accounted for by single nucleotide insertions at positions 96 and 2708, respectively (Table 1) . The carboxy-terminal sequence dierence was con®rmed in all eight B lymphocyte cDNA clones as well as the fetal spleen EST cDNA clone. Conservation between the deduced amino acid sequence of human UnpEL and the published mouse Unp sequence (Mm Unp) supports the existence of the carboxy-terminal extension (Figure 1b ). Such comparison was not possible with the amino-terminal extension, because it falls outside the boundary of the published mouse clone. Notably, the region encoding the amino-terminal extension is within the published human Unph sequence, but was considered upstream of the initiator methionine.
Second, minor dierences within the coding region were also found (Table 1) , resulting in single amino acid substitutions at residues 324, 372 and 744 of the deduced protein sequence, a pentapeptide substitution at residues 401-405, and two silent polymorphisms.
Third, two independent B cell cDNA isolates have an in-frame internal deletion of 141 nucleotides leading to a deduced protein shorter by 47 amino acids, or 5 kDa, which we designate UnpES (Table 1 ). This could be either a tissue-speci®c isoform, presumably a product of alternative splicing, or a re¯ection of individual variations in the population. For instance, The signature ubiquitin-protease domains encompassing the conserved cysteine residue at position 311 (Cys box) and the two histidines at positions 873 and 881 (His box) are boxed. The underlined segment, nucleotides 696 ± 836, is absent from two independently isolated cDNAs, encoding an isoform that is 47 amino acids shorter (UnpES). Asterisks above nucleotides 96 and 2708 denote two key dierences with the published human Unph sequence leading to extensions at both the amino and carboxy termini of the predicted protein sequence. Other dierences are detailed in Table 1 . Nucleotides +1 to +3 encode the presumed initiator methionine. For reference, the previously designated initiator methionine in GenBank sequence U20657 (amino acid 56 here) is underlined. The sequence of human UnpEL and UnpES have been deposited in the database (GenBank accession numbers AF017305 and AF017306 respectively). (b) Structure of Unp cDNAs. UnpEL and UnpES represent the two isoforms (long and short) identi®ed from cDNA libraries in this study. The structures of the published human Unp sequence (Gray et al., 1995) and mouse Unp sequence (Gupta et al., 1993) are based on GenBank accession numbers U20657 and L00681 respectively. UnpDL and UnpDS encode derivative constructs lacking the amino-terminal extension. Predicted molecular weights for each open reading frame were determined using DNASTAR software. Boxes represent aligned open reading frames. The amino-and carboxy-terminal extensions are marked by solid and white boxes at each end. Diagonal hatches, 47 amino acid fragment absent in short isoforms, presumably resulting from alternative splicing; horizontal hatches, carboxy-terminus predicted from U20657. The corresponding regions in mouse Unp are shown in dierent shading to denote homology, not identity the two silent polymorphisms observed from our study (Table 1, Lys197 and Asp367) were also harbored by the same two cDNA clones. As described below, our results support the former scenario.
Selective expression of Unp mRNA isoforms in human tissues
We looked at Unp mRNA expression from a panel of adult human tissues to test whether the heterogeneity in cDNAs re¯ects endogenous expression (Figure 2) . Indeed, Unp-speci®c transcripts appear as a closelymigrating cluster. Within the limits of resolution are at least two major isoforms approximately 3.5 and 3.7 kb in size, similar to what was observed for mouse Unp in a smaller set of tissues (Gupta et al., 1994) . The same pattern of expression was also present in human cell lines (Figure 7a ).
It is also apparent that whereas Unp mRNA was detectable in all tissues tested, their overall abundance was not high, particularly in those with proliferating cells (excepting testis). The medium-to-low level of expression on the Northern blots is consistent with the representation of cDNA clones found in our libraries (about one in 10 5 in the dT-primed library). Unp mRNA expression was highest in skeletal muscle, heart, pancreas and testis.
Lastly, the relative abundance of Unp isoforms varies from tissue to tissue: in brain, the slowermigrating species predominates, while in testis, most of the Unp-speci®c signal came from the faster-migrating species, and in skeletal muscle, both are equally represented. In light of this tissue-selective pattern of expression, it's not surprising that dierent isoforms were isolated from the various libraries. We speculate that the longer form most likely corresponds to UnpEL, and the shorter form UnpES, for the following reasons. First, the two cDNAs dier by 141 bp, consistent with the observed size dierence between the pair of transcripts. Second, if the correlation held, the tissue Northern result predicts that any cDNAs derived from brain, which expresses predominantly the longer isoform, should contain the 141 bp encoding the 47 amino acid insert, and indeed such was the case with Unph, the published sequence, which was isolated from a cortex library (Gray et al., 1995) .
Detection and analysis of UNP protein isoforms in human cell lines
We asked whether protein isoforms of Unp are present in human cell lines. Two UNP-speci®c antisera were generated: anti-ICP1, which recognizes both long and short isoforms of Unp, and anti-ICP3, which was raised against a GST-fusion with the 47 residue stretch absent from UnpES and recognizes only the long form (see Materials and methods). The antisera were characterized for their speci®city by their ability to recognize recombinant GST-UNP fusions of varying sizes and by competition with peptides (unpublished).
Indeed, all cell lines tested showed some expression of UNP protein, often present as a doublet, sometimes as a single species, as was observed with Unp transcripts (Figure 3a , UNP, top panel). In cell lines expressing two forms, incubation with anti-ICP3 ( Figure 3a , UNP-Long, bottom panel) detected only a single band, demonstrating that the slower-migrating species does indeed contain the 47 residue stretch, and the faster-migrating species does not. The presence of a doublet was also observed in a panel of lung cell lines ( Figure 7b) .
Notably, the endogenous UNP proteins had the expected mobility (105 ± 110 kDa) consistent with the open reading frames predicted by the cDNAs. This contrasts sharply with the results obtained by Gupta et al. (1994) with mouse UNP: their antibody detected a band of 180 kDa from NIH3T3 cells, far larger than predicted by either mouse or human Unp cDNAs.
The sequences of human UnpEL and Unph encode open reading frames that dier, among other changes, by the presence or absence or a 55 amino-terminal leader ( Figure 1b ). To test whether the endogenous Unp proteins can be distinguished from either form, we compared the mobility of proteins produced by three transfected recombinant cDNA constructs (UnpEL, UnpES and UnpDL) with that of the endogenous Unp ( Figure 3b ). Protein lysates from human diploid lung ®broblasts (IMR90) expressing recombinant myctagged UnpEL and UnpES from transient transfec- Arg or Ser at residue 744 change in frame resulting in 61 aa C-term extension rather than 6 aa n.a., not applicable because region of interest falls outside of clone boundary. a as shown in Figure 1a for UnpEL cDNA. GenBank sequence published by Gray et al. (1995) . . This construct is identical to myc-UnpEL except that it lacks the 55 residue amino-terminal extension, and employs the internal initiation methionine predicted from the Unph sequence. The myc-epitope extends the size of all three recombinant proteins equally, by 10 amino acid residues, or approximately 1 kDa. When transfected and endogenous UNP were directly compared on a denaturing gel, the endogenous UNP proteins in IMR90 cells (comprising at least a long isoform recognized by anti-ICP3, middle panel) migrate closely with myc-UnpEL and myc-UnpES, but more slowly than myc-UnpDL (Figure 3b , anti-ICP1, top panel). These results suggest that endogenous Unp likely contains the 55 amino-terminal leader, consistent with our assignment of the initiator methionine ( Figure 1a ).
Endogenous UNP proteins are primarily cytosolic
We monitored the sub-cellular localization of endogenous UNP in nuclear and cytosolic fractions of Hela cells (Figure 3c ) using the UNP-speci®c antibody anti-ICP1 on Western blots. Again, endogenous UNP in P-labeled probe derived from a fragment of Unp that recognizes both long and short isoforms (510 bp fragment from HpaI at 1841 to SacI at 2351), and exposed to autoradiography for 4 days. The same blots were subsequently hybridized to a b-actin probe to control for loading, and exposed for one day. Non-proliferative tissues (left) and proliferative tissues (right) were run on separate blots. Molecular weight standards in kb are marked on the left. Signal from autoradiographs were analysed as described in Materials and methods. Unp-speci®c signal from each lane was calibrated with the corresponding b-actin signal, expressed quantitatively as fold increase relative to the lowest signal in each blot and plotted. The columns representing expression in heart and skeletal muscle show two values, obtained by normalizing to only the standard 2 kb form of tubulin (black), or to both it and the 1.8 kb isoform (grey) both the cytoplasmic fractions and in whole cell lysate has the expected mobility, slightly slower than recombinant myc-UnpDL. Endogenous UNP immunoreactivity co-fractionates with a-tubulin, a cytosolic marker, and not with BRCA1 or c-myc, both nuclear markers. These results show that UNP is localized primarily in the cytosol, and not in the nucleus.
Recombinant UNP is localized primarily in the cytoplasm and is not exclusively nuclear
We could not visualize the localization directly in cells by immunocytochemistry because our anti-UNP antibodies stained cells poorly. Instead, we tested immunostaining of transfected myc-UNP in IMR90 cells using anti-myc antibody (Figure 4a ± f) . Expression of both myc-UnpEL and myc-UnpES is observed throughout the cell, with frequent examples of convincing nuclear-exclusion (d, e ± f), indicating a primarily cytoplasmic localization (Table 2) . We favor the possibility that at least some of the whole-cell staining seen with Unp is due to masking of the nucleus by the strong cytoplasmic signal, and that unambiguous nuclear-exclusion was evident only in fortuitously well-positioned nuclei. The related question of whether the apparent additional expression in the nucleus has any physiological basis, perhaps related to the cell cycle, or is an artifact of overexpression remains to be determined. For instance, under the same conditions, transfected myc-wee1 localized both exclusively in the nucleus, as expected (Heald et al., 1993) , and throughout the cell in other instances (Table  2) , presumably due to overexpression. To further ensure that the cytoplasmic localization of mycUnpEL is independent of the chosen epitope, another construct, FLAG-UnpEL, was similarly tested in a transient transfection assay, and detected by immunocytochemistry using a monoclonal antibody raised against the FLAG epitope (Eastman Kodak, New Haven, CT). The staining pattern was indistinguishable from that of myc-UnpEL (data not shown).
The same results were obtained whether visible (a, d) or¯uorescent (b, e) detection was used. Taken together, the endogenous fractionation and immunostaining of myc-UNP indicate a primarily cytoplasmic localization for both UNP isoforms, which is in direct disagreement with published reports of mouse UNP as a uniquely nuclear protein (Gupta et al., 1994) .
We also asked whether myc-tagged UNP expression constructs harboring either the short isoform UnpES or mutant Unp derivatives (UnpDL, UnpEL-C311A, UnpES-C264A) led to any changes in intracellular localization ( Figure 4 , Table 2 ). No major dierences were observed: all showed whole-cell localization with no evidence of uniquely-nuclear staining. Exclusively cytoplasmic staining was observed at only 1% in mycUnpDL. Because of the caveat of overexpression, we can only interpret these results with caution. Qualitatively, we conclude that neither the internal 47 residue stretch, nor the amino-terminal 55 amino acids, nor the conserved cysteine appear to play a major role in determining the speci®city of compartmentation of UNP.
Unp isoforms encode functional deubiquitination enzymes
An obvious question is whether both isoforms of Unp encode functional deubiquitination enzymes. Because both contain the signature motifs for these enzymes, namely the conserved Cys and His boxes, we expected them to be active at least in the standard bacterial assay for deubiquitination that de®nes other members of the family (Papa and Hochstrasser, 1993) . In this assay, an arti®cial fusion linking the last amino acid of mammalian ubiquitin (glycine 76) to bacterial bgalactosidase serves as the substrate, and a GST-UNP fusion (Figure 5b ) provides the enzymatic activity in question. Presence of deubiquitinating activity is evidenced by the appearance of a faster-migrating form of b-galactosidase, without the attached ubiquitin moiety (Figure 5a ). Our results show that indeed, both UnpEL and UnpES isoforms cleaved ubiquitin from the fusion substrate eciently, while their corresponding active-site mutants (cysteine-to-alanine) did not, demonstrating the critical role of that residue (Cys 311 in UnpEL and Cys 264 in UnpES) in the deubiquitination reaction. Presumably, it is the site for ubiquitin thioester formation. These results also suggest that the internal 47 amino acid stretch that distinguishes UnpEL from UnpES is not indispensable to the cleavage reaction itself. Whether it may function in vivo to govern substrate selectivity in dierent tissues is an open question. We also examined the deubiquitinating activity of UnpDL and UnpDS and found both capable of removing ubiquitin from the substrate (Figure 5a) , demonstrating that the amino-terminal 55 residues are not absolutely required for catalysis. We note that although the cleavage reactions appears less ecient than those of UnpEL and UnpES, the current results are best interpreted qualitatively, because the ratios of substrate to enzyme are not exactly controlled in this in vivo bacterial system. As with the internal 47 amino acid stretch, whether the amino-terminal 55 residues play any role in the selection of biological substrates remains to be determined.
Unp maps to human chromosome 3p21.31
Intrigued by the many dierences between the reported properties of Unp and those observed in this study, we decided to map the chromosomal position of UnpEL. A genomic clone of UnpEL was obtained from screening a PAC1 library which was then used as ā ourescent probe to label human metaphase chromosomes ( Figure 6 ). Speci®c hybridization to the mid short arm of a group A chromosome (Figure 6a ) was subsequently identi®ed as 3p21.31 when double-labeled with a probe speci®c to the centromere of chromosome 3 (Figure 6b) . Notably, the labeling was speci®c to a Figure 4 Cellular localization of recombinant human Unp cDNAs. IMR90 cells transfected with plasmids expressing myc-tagged UnpEL (a, ± f) or myc-tagged Wee1 (g ± i) were analysed by immunostaining with an anti-c-myc monoclonal antibody. Staining was detected either by immunoperoxidase activity (a, d, g, brown) or immuno¯uorescence (b, e, h, red) followed by Hoechst staining to identify nuclear material (c, f, i, blue). The immuno¯uorescent and Hoechst stains are shown in pairs of identical frames visualized through dierent ®lters (b ± c, e ± f, h ± i). Both whole-cell staining (a ± c) and distinctly cytoplasmic, non-nuclear staining pro®les (d ± f) were observed with myc-UnpEL (Table 2) . Nuclear staining of myc-Wee1 served as control (g ± i) (41) 165 ( single chromosomal region and not to multiple positions as expected if Unp were a member of a near-identical gene family. Since the map position obtained by us is in complete agreement with the published location of Unph, the possibility that Unph and UnpEL derive from dierent genes on dierent chromosomes is remote.
Variable expression of Unp in a panel of lung tumor cell lines
Studies of allele loss in lung tumors and cell lines have de®ned chromosomal region 3p21.3 as frequently deleted in lung cancers, speci®cally small-cell cancer (SCCL) (Hibi et al., 1992; Whang-Peng et al., 1992) , leading to the expectation that the region encompasses a tumor suppressor gene. We compared the abundance of Unp mRNA (Figure 7a ) in a panel of eight human lung tumor cell lines to those in normal adult lung and normal diploid lung ®broblasts (IMR90). We chose to include cell lines derived from each class of lung tumors: four small-cell (H345, H69, H82, H446), two squamous (H520, SK-MES1), one large cell (H460), and one unspeci®ed tumor of the lung (A549). Unp levels in each sample were normalized to those of bactin, a ubiquitous transcript, and expressed as fold increase over IMR90. One sample, H345, had only trace amounts of poly(A) + mRNA and was excluded from subsequent analysis. We observed no signi®cant misregulation of Unp expression in any of the cell lines when compared to the non-tumor samples, either in abundance or size. Variations in abundance observed among samples were subtle (less than twofold), no greater than the dierence observed between the adult lung sample and the lung ®broblast sample. However, when the comparison was made with UNP protein expression normalized to a-tubulin, a tentative correlation between abundance and tumor origin was noted (Figure 7b ). All four lines of small cell lung origin as well as a squamous carcinoma cell line (H520) had reduced expression levels, ranging from approximately one third (H69), two thirds (H345 and H446) to four-®fths (H82 and H520) of the levels in IMR90. The remaining three lung tumor cell lines had levels equal to or slightly higher than IMR90 (A549, H460, SKMES1). Endogenous UnpEL is present in all the cell lines as judged by immunoreactivity with anti-ICP3 (top panel). Likewise, the presence of a smaller, closely-migrating species, presumably UnpES, is seen in most cell lines in the anti-ICP1 immunoreactive blot (middle) that is absent in the anti-ICP3 blot (top). The presence of UNP protein in all samples tested demonstrates that each cell line contains at least one chromosomal copy of the Unp locus. Nevertheless, the reduced expression observed in the limited set of small cell carcinoma cell lines ful®lls one criterion for candidate tumor suppressor genes at 3p21.3.
Discussion
In light of the results presented in this study, we propose that the human Unp locus at chromosome 3p21.31 encodes at least two isoforms UnpEL and UnpES, distinguished by the presence or absence of an internal 47 amino acid stretch, whose relative abundance varies from tissue to tissue. The proteins have a molecular mass of approximately 105 ± 110 kDa and can be found either exclusively in the cytoplasm or throughout the cell. Both isoforms possess a deubiquitinating activity that requires the presence of a critical cysteine residue, the presumed thiol-forming active site in the conserved Cys box unique to this family of ubiquitin proteases. Finally, although expression of Unp transcripts appear unaltered when a panel of lung cancer cell lines was compared to normal ®broblasts or adult lung  IMR90  H345  H446  H69  H82  A549  H460  H520  SKMES  MCF7  myc-UnpEL  myc-UnpES   IMR90  H345  H446  H69  H82  A549  H460  H520 (IMR90), a non-lung carcinoma line (MCF7, breast adenocarcinoma) and normal adult lung tissue. The lung carcinoma cell lines comprise four small cell carcinoma (NCl-H345, H446, H69, H82), two squamous carcinoma (NCl-H520, SK-MES1), one non-small-cell carcinoma (H460), and one unspeci®ed lung tumor line (A549). The blot was hybridized with a 32 P-labeled probe derived from Unp (as described in Figure 2 ) and exposed for 60 h. The b-actin control blot was exposed for 24 h. Molecular weight standards in kb are shown at left. Signal from autoradiographs were analysed as described in Materials and methods. Unp-speci®c signal from each lane was calibrated with the corresponding b-actin signal, expressed quantitatively as fold increase relative to the signal for IMR90 and plotted. (b) Western blot analysis of cellular protein extracts (150 mg per lane) prepared from the same panel of human cell lines described above. For comparison, extracts from IMR90 cells transfected with recombinant myc-tagged Unp plasmids were also included. The same immunoblot was reacted sequentially with an antiserum speci®c to the long isoform of UNP (anti-ICP, top panel); an anitypuri®ed antiserum to both isoforms of UNP (anti-ICP1, middle panel); and an anti-tubulin antiserum (bottom panel), with stripping between each antiserum incubation. Unp-speci®c signal (middle panel) from each lane was calibrated with the corresponding atubulin signal (bottom), expressed quantitatively as fold increase relative to the signal for IMR90 and plotted normal lung tissue, the abundance of UNP protein is slightly reduced in all four small cell carcinoma cell lines tested.
Although some of the above results apparently contradict published observations about Unp, we suggest alternative interpretations to the published data that may reconcile these dierences. The variations in cDNA sequence resulting in a dierent predicted amino acid sequence can easily be explained by errors in DNA sequence determination. The designation of UnpEL coding sequence further eliminates the small open reading frames whose unusual presence in the 5' untranslated sequence of Unph required explanation. The carboxy-terminal extension in UnpEL is conserved in mouse Unp, and the amino-terminal extension neatly explains why UnpDL protein (using the internal methionine initiator predicted in Unph) appears smaller than endogenous UNP. The unaccountably large 180 kDa nuclear protein described from NIH3T3 cells is most probably not mouse UNP, but rather an unrelated cross-reacting species recognized by the antiserum. We have observed a similarly-sized band unrelated to Unp which is recognized by our crude anti-Unp antisera but not by the anity-puri®ed antisera (unpublished observations). We think it unlikely that the discrepancy be attributed solely to species dierences, given the high conservation generally observed between mouse and human proteins. Last, unlike the ®ndings of Gray et al. (1995) , we found no evidence for overexpression of Unp transcripts in cell lines derived from small cell lung carcinomas. This could be due to either the dierent cell lines tested, or dierences in procedures used for normalization and quanti®cation. We have also not tested primary tumor samples.
The tumor suppressor gene in 3p21.3 remains elusive. Recent advancements in positional cloning coupled with the ever-growing list of DNA sequences in databases have helped identify several candidates that map to the region, including MLH1, encoding the human homolog of the E. coli DNA mismatch repair enzyme mutL, and SEAM, a gene encoding a semaphorin that appears deleted in primary tumors (Roche et al., 1996) . Reports of genes mapping to 3p21.3 with elevated expression in lung cancer cell lines or tumors include the alpha subunit of intergrin (Hibi et al., 1994) , the multifunctional protein 37LRP/p40 (Jackers et al., 1996) and Unph (Gray et al., 1995) . Our observation that levels of UNP protein are reduced, rather than elevated, relative to normal lung ®broblasts in all four small cell lung tumor lines tested leaves open the possibility that Unp may be a candidate for the tumor suppressor locus implicated in the pathogenesis of lung tumors attributed to 3p21.3. Further clarification awaits investigation of protein levels in direct tumor samples.
It is formally conceivable that Unp may yet possess oncogenic potential of its own. Since details of the initial identi®cation of Unp are unpublished, it is not clear whether the original retroviral insertion around the Unp locus in mice resulted in any transforming phenotype. Reports of the transforming potential of Unp constructs in athymic mice await con®rmation with larger sample sizes than those initially reported by Gupta et al. (1994) . Theoretically, a locus with both transforming potential and tumor suppressing activity need not be mutually exclusive; for instance, TGFb exerts opposing eects on dierent target cells (for review, see Kingsley, 1994; Massague et al., 1994) , and the tumor suppressor p53 was originally identi®ed as a proto-oncogene (Linzer and Levine, 1979) .
The question of what physiological role the family of deubiquitination enzymes plays remains open. Do they act soley to debranch ubiquitin from multichains for recycling purposes, or do they have a more subtle regulatory function in determining the stability of speci®c target substrates in the cell? Ultimately, the answer lies in elucidating the biological targets for each member of the family, including Unp, and in understanding the mechanisms specifying both catalysis and target selection.
Materials and methods
Cell culture
All cell lines were obtained from American Type Culture Collection. The lung panel includes cell lines derived from human small cell lung carcinoma (NCI H345, NCI H69, NCI H82, NCI H446), large cell carcinoma (NCI H460), squamous cell carcinoma (NCI H520, SK-MES-1), an unspeci®ed human lung carcinoma (A549), and human fetal diploid lung ®broblasts (IMR90). Human cell lines derived from other tissues include transformed embryonic kidney ®broblasts (293S), cervical carcinoma (HeLa), and breast adenocarcinoma (MCF7). Cells were maintained according to recommendations in either RPMI 1640 medium (Life Technologies) or Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum, 2 mM glutamine, 100 U/mL penicillin and 1 mg/ mL streptomycin.
Isolation of human Unp cDNAs
Database searches for Unp clones were performed using the BLAST network service of the NCBI. The dbEST clone number 72923, encoding a 1.3 kb fragment from the 3' end of Unp cDNA, was from a human fetal spleen library and was purchased from Research Genetics. Using part of the insert as probe, 57 positives were obtained from screening 2610 6 plaques of a Epstein-Barr virus transformed human B lymphocyte, poly dT-primed cDNA library (Durfee et al., 1993) , of which eight were plaque-puri®ed, excised, and their junction DNA sequence determined. The two longest clones (pIC644 and pIC648) were sequenced in their entirety. A retinal cDNA fragment (from nucleotide 505 ± 1236 of UnpEL) was obtained by PCR ampli®cation of a human retinal cDNA library (Nathans and Hogness, 1984) and subcloning into pUC118 (pIC643). Last, a cDNA clone was isolated from a human T cell library (random and poly dT primed, Stratagene) that contained more 5' sequence than all the others (pAF36). Full-length UnpEL, UnpES, and UnpDL were reconstructed by replacing the 5' end of pIC644, which contains full-length UnpDS, with appropriate 5' fragments from the other clones. The DNA sequences of all four full-length cDNA clones, pertinent regions of all the parent cDNA clones along with that of the dbESTclone 72923, were determined on both strands (ABI) and analysed using the Sequencher software.
Construction of the cysteine to alanine mutation
The conserved cysteine at the Cys box motif was changed to alanine by oligonucleotide mutagenesis. Coding and noncoding strand oligonucleotides containing the mutation (MIC156, 5'-GGAAACCTGGGAAACACCGCCTTCAT-GAACTCCGCTTTG-3' and MIC157, 5'-CAAAGCG-GAG TTCATGAA GGCGGTGTTTCCCAGGTTTCC -3') were each paired with separate oligonucleotides (MIC157 with MIC130 and MIC156 with MIC139) to PCR amplify two overlapping fragments. The latter were subsequently combined in a ®nal PCR reaction with oligonucleotides MIC130 and MIC139, digested with EcoRI and XbaI, cloned into plasmids with UnpEL, UnpES, UnpDL, and UnpDS to replace the wild type fragment. The resulting clones were sequenced on both strands to con®rm the presence of the desired mutation.
Northerns
The human adult multiple tissue Northern blots were purchased from Clontech and hybridized as below. For the lung panel Northern blots, poly(A) + RNA was isolated from approximately 1610 8 cells using the Invitrogen Fast Track 2.0 kit. RNA yield was determined by absorbance at 260 nm. 5 mg of mRNA was loaded per lane and electrophoresed through a 1.2% agarose gel containing formaldehyde at a ®nal concentration of 2.2 M. The mRNA was transferred onto a Nytran + membrane (Schleicher and Schuell) by capillary action. The membrane was hybridized overnight at 428C with a 32 P-labeled probe (44610 8 c.p.m./mg DNA) derived from either nucleotides 1874 ± 3112 of UnpEL cDNA or human bactin cDNA (Clontech) in 56SSC, 56Denhardt's solution, 30% formamide, 1% SDS, and 200 mg/mL denatured salmon sperm DNA. The ®lter was washed at 658C in 0.26SSC and 0.1% SDS, and exposed to X-ray ®lm (Fuji) with an intensifying screen at 7808C.
Westerns
Unless speci®ed otherwise, whole-cell extracts were prepared as described (Tam et al., 1994) , in lysis buer (50 mM TrisHCl (pH 7.4), 0.25 mM NaCl, 1% Triton-X-100, 1 mM EDTA, 50 mM NaF, 1 mM DTT, 0.1 mM Na 3 VO 4 ) with protease inhibitors (0.1 mM phenylmethylsulfonyl¯uoride, 1 mg/ml leupeptin, 10 mg/ml L-1 chlor-3-(4-tosylamido)-4-phenyl-2-butanone, 1 mg/ml aprotinin, 10 mg/ml L chlor-3-(4-tosylamido)7-amino-2-heptanone hydrochloride). After incubation on ice for 60 min, the samples were centrifuged at 14 000 r.p.m. in an Eppendorf microfuge for 10 min at 48C to recover the supernatant. The amount of protein was determined using Bio-RAD protein assay. Extracts were separated by 8% SDS polyacrylamide gel (Novex) electrophoresis and transferred onto a nitrocellulose membrane (Novex). Membranes were blocked in 5% milk in PBS/0.1% Tween (PBST) for 1 h, incubated with primary antibody in 1% milk in PBST for 2 h, then with the appropriate horseradish peroxidase-linked secondary antibody, and detected by enhanced chemiluminescence (Pierce) according to the manufacturer's instructions. Membranes that were reblotted were ®rst incubated in 0.2 N NaOH for 10 min at room temperature and washed in PBST. Incubations were at 258C.
Antibodies
The rabbit antiserum anti-ICP1 was raised against the peptide CHFSKADTIATIEK derived from residues 154 ± 167 from the predicted sequence of UNP, and anity puri®ed with a CNBr-activated sepharose column (Pharmacia) coupled with the same peptide. Anity-puri®ed anti-ICP1 was used at 0.3 mg/ml for Westerns, and detects both long and short isoforms of UNP. The rabbit antiserum anti-ICP3 was raised against the GST-fusion peptide derived from residues 233 ± 279 from the predicted sequence of UNP, and used at 1 : 5000 dilution. It speci®cally recognizes the long isoforms of UNP. The rabbit anti-b-galactosidase antibody was from Cappel (Organon Teknika) and used at 1 : 3000 dilution. The mouse monoclonal antibodies speci®c for c-myc and BRCA1 were both from Oncogene Research Products (Calbiochem) and used at 1 : 100. The anti-mouse or antirabbit HRP-linked IgG antibodies were from Amersham and used at 1 : 4000 dilution.
Band quanti®cation and anlaysis
Autoradiograms of Northerns and Westerns were analysed using the Gel Doc 1000 (Biorad) image analysis system and Molecular Analyst/Macintosh software (Biorad). Signals used for the analyses were in the linear range; overexposed autoradiograms with saturated signals were avoided.
Transfection of recombinant Unp clones
The myc-tagged-Unp cDNA expression constructs were driven by the human CMV promoter in a pcDNA3 (invitrogen) vector backbone derived from the plasmid CMV-myc-Wee1, a kind gift from Dr Frank McKeon (Heald et al., 1993) . IMR90 cells were transfected using the Transit LT1 polyamine reagent (Mirus) according to the manufacturer's instructions. Brie¯y, cells were seeded at 40% con¯uence in 10 cm plates with 0.2% gelatin-coated coverslips. The next day, 110 ml of Transit LT1 was pre incubated in 500 ml of Opti-Mem reduced serum media (Life Technologies), followed by addition of 10 mg of each DNA (myc tagged versions of UnpEL, UnpES, UnpEL-C311A, UnpES-C264A, UnpDL, or Wee1) and incubation for 10 min. Cells were rinsed then replaced with Opti-MEM medium. The DNA mixture was added to the cells and incubated for 8 h at 378C, 5% CO 2 . The medium was removed and replaced with DMEM supplemented with 10% fetal calf serum. Cells were harvested by scraping 40 h later.
Cell fractionation
The protocol for cell fractionation was adapted from Lee et al., (1987) . Hela cells (four 15 cm plates *6610 7 ) were rinsed twice in PBS, collected by scraping in PBS/0.5 mM EDTA, and pelleted at 1500 r.p.m. for 5 min (Beckman, GS-6KR). All subsequent steps were at 48C. After resuspension in cold hypotonic RSB buer (10 mM HEPES pH 6.2, 10 mM NaCl, 1.5 mM MgCl 2 and proteinase inhibitors), one quarter of the cells were pelleted and resuspended in RIPA (50 mM Tris, pH 8.0/ 150 mM NaCl/0.1% SDS/0.1% sodium deoxycholate/1% NP40 with phosphatase and protease inhibitors) lysis buer (Whole cell lysate). The remaining cells were rinsed again in RSB, lysed by 20 strokes in a tight-®tting Dounce homogenizer in 3 ml volume, and centrifuged at 1500 r.p.m. for 15 min (Beckman, GS-6KR). The pellet was rinsed once more in RSB, and then resuspended in RIPA lysis buer (Nuclear fraction). The supernatant was further fractionated into cytosolic (supernatant) and membrane (pellet) components by centrifugation at 35 000 r.p.m. for 30 min (Beckman SW40Ti). After determining protein concentrations, samples were resuspended in Laemmli buer.
Immunocytochemistry
Transfected cells on coverslips were treated with ice-cold acetone:methanol (1 : 1) for 3 ± 5 min, rinsed in PBS, reacted with 5% normal horse serum to block nonspeci®c binding, then with anti-myc monoclonal antibody (Oncogene Research Products) at 10 mg/ml for 1 h. Treatment with biotinylated-secondary-IgG (1 h) was followed by incubation with avidin-biotin-peroxidase complex and visualization of immunoperoxidase activity by incubation with diaminobenzidine (DAB, 0.5 mg/ml) and hydrogen peroxide (0.015%) as recommended by the manufacturer (Vector Labs). For immuno¯uorescence staining, the ®xed coverslips were ®rst blocked in DMEM, 10% fetal calf serum, 0.1% azide (DFA) for 10 min, incubated with antimyc (1 : 10 in DFA) for 1 h, then treated for 30 min with biotinylated anti-mouse IgG (1 : 50 in DFA) and subsequently, Texas Red conjugated streptavidin (1 : 100 in DFA) for 30 min. All incubation steps were at 258C. To visualize nuclear DNA, Hoechst reagent (1 : 10 000 in PBS) was added to each coverslip for 2 min. Coverslips were mounted onto slides with 90% glycerol/PBS.
Deubiquitination assay
GST-Unp fusion constructs were made in pGEX-4T vectors (Pharmacia). The ubiquitin-b-galactosidase fusion (pAF6) was constructed in two steps. First, coding and noncoding strand oligonucleotides engineered with SalI and NcoI sites wre used to PCR amplify the human ubiquitin cDNA using dbEST clone 37797 (Research Genetics) as a template, and the digested product was cloned into pLacF vector containing the E. coli lacZ gene (gift from J Peschon). The ubiquitin-b-galactosidase fusion was then digested with SalI and BglII and subcloned into pACYC184 (New England Biolabs) which harbors the p15A origin of replication and the gene for chloramphenicol-resistance. The GST-Unp fusion constructs were cotransformed with pAF6 into MC1061 cells. Ampicillin plus chloramphenicol resistant transformants were assayed for deubiquitination activity. 50 mL of ech bacterial transformant were grown at 378C until A 600 =0.4, then induced with 1 mM IPTG at 258C with vigorous shaking for 4 h. Cells were harvested at 4200 r.p.m. for 20 min at 48C, then lysed in 1% Triton/PBS by 4615 s sonications on ice. The supernatant was recovered by centrifuging at 14 000 r.p.m. for 10 min at 48C. Extracts were resolved by 8% SDS ± PAGE, and analysed by immunoblotting as described. For detection of b-galactosidase in the deubiquitination assay, 50 ± 800 ng of total extracts suced, depending on the success of induction. To monitor the presence of GST-UNPs, approximately tenfold amounts (8 ± 10 mg) of proteins were loaded.
Chromosomal localization
Chromosomal mapping of human Unp by¯uorescence in situ hybridization (FISH) was performed by Genome Systems (St Louis, Missouri). A 2.9 kb Unp cDNA fragment (XhoI fragment of pIC653) was used to screen a human genomic Pac library containing an average insert size of 120 kb. A single positive clone was obtained which following DNA puri®cation was labeled with digoxigenin dUTP by nick translation and used as a probe for FISH. Labeled probe was combined with sheared human DNA and hybridized to normal metaphase chromosomes derived from PHA-stimulated peripheral blood lymphocytes in a solution containing 50% formamide, 10% dextran sulfate and 26SSC. Speci®c hybridization signals were detected by incubating the hybridized slides in¯uoresceinated antidigoxigenin antibodies followed by counterstaining with DAPI, with or without cohybridization with biotin-labeled, chromosome-speci®c probes. A total of 80 metaphase cells were analysed with 69 exhibiting speci®c labeling.
